Not applicableLooking for participantsNCT07377058What this trial is testingRCT of Tocilizumab for Anti-MDA5+DMWho this might be right forDermatomyositis Peking Union Medical College Hospital 110
Testing effectiveness (Phase 2)Looking for participantsNCT07486869What this trial is testingEmapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) StudyWho this might be right forDermatomyositisDermatomyositis Sine MyositisDermatomyositis With Myopathy+4 more University of Miami 5
Post-approval studies (Phase 4)UnknownNCT05375435What this trial is testingEfficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive DermatomyositisWho this might be right forDermatomyositis, Adult TypeInterstitial Lung Disease The First Affiliated Hospital with Nanjing Medical University 120
Not applicableLooking for participantsNCT06203249What this trial is testingMicroecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung DiseaseWho this might be right forMicrobiomeImmune FunctionAnti-MDA5 Antibody Positive Dermatomyositis Chinese PLA General Hospital 50
Post-approval studies (Phase 4)UnknownNCT04966884What this trial is testingThe Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis PatientsWho this might be right forDermatomyositis, Adult Type First Affiliated Hospital Xi'an Jiaotong University 20